AstraZeneca AB v. Apotex Inc. et al
| AstraZeneca AB |
| Apotex Inc. and Apotex Corp. |
| 1:2024cv00551 |
| May 6, 2024 |
| U.S. District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 1 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 2, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aposherm Delaware Holdings Corporation for Apotex Corp.; Corporate Parent Apotex Pharmaceutical Holdings, Inc. for Apotex Inc. filed by Apotex Corp., Apotex Inc.. (Phillips, John) |
| Filing 9 STIPULATION and Proposed Order to Extend Time - filed by Apotex Corp., Apotex Inc.. (Haney, Megan) Modified on 7/2/2024 (nms). |
SO ORDERED, re #9 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Apotex Corp. answer due 9/3/2024; Apotex Inc. answer due 9/3/2024). Signed by Judge Richard G. Andrews on 7/2/2024. (nms)
|
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (nms) |
| Filing 8 WAIVER OF SERVICE returned executed by AstraZeneca AB: For Apotex Corp. waiver sent on 5/6/2024, answer due 7/5/2024. (Silver, Daniel) |
| Filing 7 WAIVER OF SERVICE returned executed by AstraZeneca AB: For Apotex Inc. waiver sent on 5/6/2024, answer due 7/5/2024. (Silver, Daniel) |
| Filing 6 Summons Issued as to Apotex Corp. on 5/6/2024; Apotex Inc. on 5/6/2024. (Attachments: #1 Summons Issued)(mpb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB filed by AstraZeneca AB. (mpb) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,919,598; 8,501,698; 8,685,934; 9,616,028. (mpb) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 3/22/2024. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 9/22/2026. (mpb) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
| Filing 1 COMPLAINT filed against Apotex Corp., Apotex Inc. ( Filing fee $ 405, receipt number ADEDC-4400758.) - filed by AstraZeneca AB. (Attachments: #1 Exhibit A-D, #2 Civil Cover Sheet)(mpb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
